Chloride Channel 7 (ClCN7) Gene Mutations and Autosomal Dominant Osteopetrosis, Type II

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Bone and Mineral Research

• Publication date

  2003-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1359/jbmr.2003.18.8.1513PMID 12929941
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Measurement of tartrate-resistant acid phosphatase and the brain isoenzyme of creatine kinase accurately diagnoses type II autosomal dominant osteopetrosis but does not identify gene carriers.

  2002cited by this paper
• The mutational spectrum of human malignant autosomal recessive osteopetrosis.

  2001cited by this paper
• Exclusion of the chromosomal 1p21 region in a large pedigree with a phenotypic variant of type II autosomal dominant osteopetrosis

  2001cited by this paper
• Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man.

  2001influential reference
• Mapping of autosomal dominant osteopetrosis type II (Albers-Schönberg disease) to chromosome 16p13.3.

  2001cited by this paper
• Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene.

  2001influential reference
• Mutations in the a3 subunit of the vacuolar H(+)-ATPase cause infantile malignant osteopetrosis.

  2000cited by this paper
• Further Evidence for Genetic Heterogeneity Within Type II Autosomal Dominant Osteopetrosis

  2000cited by this paper
• Serum Creatine Kinase Isoenzyme BB in Mammalian Osteopetrosis

  2000cited by this paper
• Bone resorption by osteoclasts.

  2000cited by this paper
• Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis

  2000cited by this paper
• Type II autosomal dominant osteopetrosis (Albers-Schönberg disease): clinical and radiological manifestations in 42 patients.

  2000cited by this paper
• The CLC chloride channel family

  1999cited by this paper
• Bone mineral density and laboratory evaluation of a type II autosomal dominant osteopetrosis carrier.

  1999cited by this paper
• Locus heterogeneity of autosomal dominant osteopetrosis (ADO).

  1999cited by this paper
• Localization of a gene for autosomal dominant osteopetrosis (Albers-Schönberg disease) to chromosome 1p21.

  1997cited by this paper
• Searching for gene defects that cause high bone mass.

  1997cited by this paper
• The VITESSE algorithm for rapid exact multilocus linkage analysis via genotype set–recoding and fuzzy inheritance

  1995cited by this paper
• Positional cloning moves from perditional to traditional

  1995cited by this paper
• Faster sequential genetic linkage computations.

  1993cited by this paper
• Osteopetrosis

  1987cited by this paper
• Easy calculations of lod scores and genetic risks on small computers.

  1984cited by this paper
• [Osteopetrosis in adults].

  1974cited by this paper
• OSTEOPETROSIS: A Clinical, Genetic, Metabolic, and Morphologic Study of the Dominantly Inherited, Benign Form

  1968cited by this paper
• Osteopetrosis in adults.

  1955cited by this paper

• PDE4B promotes JNK/NLRP3 activation in the nucleus pulposus and mediates intervertebral disc degeneration

  2025cites this paper
• Prevalence of loss-of-function, gain-of-function and dominant-negative mechanisms across genetic disease phenotypes

  2025cites this paper
• Fractures are Highly Correlated with Bone Density and Inversely Correlated with Bone Turnover Markers in Autosomal Dominant Osteopetrosis.

  2025cites this paper
• Metabolomics study of osteopetrosis caused by CLCN7 mutation reveals novel pathway and potential biomarkers

  2025cites this paper
• Patient-Reported Outcomes in Autosomal Dominant Osteopetrosis: Findings from the Osteopetrosis Registry Study.

  2024cites this paper
• Autosomal Dominant Osteopetrosis (ADO) caused by a Missense Variant in the TCIRG1 Gene.

  2024cites this paper
• Downregulation of chloride voltage-gated channel 7 contributes to hyperalgesia following spared nerve injury

  2024cites this paper
• Effect of Roflumilast, a Selective PDE4 Inhibitor, on Bone Phenotypes in ADO2 Mice

  2024cites this paper
• The PDE4 Inhibitors Roflumilast and Rolipram Rescue ADO2 Osteoclast Resorption Dysfunction

  2024cites this paper
• Gain-of-function variants in CLCN7 cause hypopigmentation and lysosomal storage disease

  2024cites this paper
• Effect of Allele-Specific Clcn7G213R siRNA Delivered Via a Novel Nanocarrier on Bone Phenotypes in ADO2 Mice on 129S Background

  2024influential citation
• CRISPR/Cas9-Mediated Gene Correction in Osteopetrosis Patient-Derived iPSCs.

  2023cites this paper
• Unusual Cortical Phenotype After Hematopoietic Stem Cell Transplantation in a Patient With Osteopetrosis

  2022cites this paper
• Bone marrow transplantation as a therapy for autosomal dominant osteopetrosis type 2 in mice

  2022cites this paper
• Natural History of Type II Autosomal Dominant Osteopetrosis: A Single Center Retrospective Study

  2022cites this paper
• The Role of the Lysosomal Cl−/H+ Antiporter ClC-7 in Osteopetrosis and Neurodegeneration

  2022cites this paper
• Chloroquine Increases Osteoclast Activity in vitro but does not Improve the Osteopetrotic Bone Phenotype of ADO2 Mice.

  2021cites this paper
• Clinical and molecular characterization of five Chinese patients with autosomal recessive osteopetrosis

  2021cites this paper
• CLCN7 Gene

  2020cites this paper
• The Genetic Architecture of High Bone Mass

  2020cites this paper
• Pathobiologic Mechanisms of Neurodegeneration in Osteopetrosis Derived From Structural and Functional Analysis of 14 ClC‐7 Mutants

  2020cites this paper
• A Novel Variant in CLCN7 Regulates the Coupling of Angiogenesis and Osteogenesis

  2020cites this paper
• Molecular basis of bone diseases

  2020cites this paper
• Pathobiologic Mechanisms of Neurodegeneration in Osteopetrosis Derived from Structural and Functional Analysis of 14 ClC-7 Mutants. Journal of Bone and Mineral Research.

  2020cites this paper
• Technologies, Tools, and Genetic Models to Study Osteoclasts

  2019cites this paper
• Osteoclast Activity: Bone Resorption, Polarization, Acidification, Proton Pumps, and Chloride Channels

  2019cites this paper
• Genotyping, generation and proteomic profiling of the first human autosomal dominant osteopetrosis type II-specific induced pluripotent stem cells

  2019cites this paper
• Journal of Bone and Mineral Research: Volume 34, Number 1, January 2019

  2019influential citation
• Testing the Cre-mediated genetic switch for the generation of conditional knock-in mice

  2019cites this paper
• Interferon Gamma‐1b Does Not Increase Markers of Bone Resorption in Autosomal Dominant Osteopetrosis

  2019cites this paper
• Molecular signaling in bone cells: Regulation of cell differentiation and survival.

  2019cites this paper
• Study of Surface Mechanical Parameters on Composite Biological Structures by using Non-Destructive Optical Tests

  2019cites this paper
• CLC Chloride Channels and Transporters: Structure, Function, Physiology, and Disease.

  2018cites this paper
• Cervical spine fractures in osteopetrosis: a case report and review of the literature

  2018cites this paper
• Human Genetics of Sclerosing Bone Disorders

  2018cites this paper
• ADULT OSTEOPETROSIS

  2018cites this paper
• Sclerosing Bone Disorders

  2018cites this paper
• Enhanced Activation of Rac1/Cdc42 and MITF Leads to Augmented Osteoclastogenesis in Autosomal Dominant Osteopetrosis Type II

  2018influential citation
• Sclerosing bone dysplasias.

  2018cites this paper
• CLCN7 and TCIRG1 mutations in a single family: Evidence for digenic inheritance of osteopetrosis.

  2018cites this paper
• Cortical bone quality affectations and their strength impact analysis using holographic interferometry.

  2018cites this paper
• Phenotypic severity of autosomal dominant osteopetrosis type II (ADO2) mice on different genetic backgrounds recapitulates the features of human disease.

  2017cites this paper
• Novel mutations of CLCN7 cause autosomal dominant osteopetrosis type II (ADOII) and intermediate autosomal recessive osteopetrosis (ARO) in seven Chinese families

  2017cites this paper
• CLCN7-Related Osteopetrosis

  2016cites this paper
• Two novel mutations of CLCN7 gene in Chinese families with autosomal dominant osteopetrosis (type II)

  2016cites this paper
• Novel CLCN7 mutation identified in a Han Chinese family with autosomal dominant osteopetrosis-2

  2016cites this paper
• Novel mutations of CLCN7 cause autosomal dominant osteopetrosis type II (ADO-II) and intermediate autosomal recessive osteopetrosis (IARO) in Chinese patients

  2016cites this paper
• Enhanced but hypofunctional osteoclastogenesis in an autosomal dominant osteopetrosis type II case carrying a c.1856C>T mutation in CLCN7

  2016cites this paper
• Tuberous sclerosis, polycystic kidney disease and mucolipidosis III gamma caused by a microdeletion unmasking a recessive mutation

  2015cites this paper
• Biomarker Genes in Autosomal Dominant Osteopetrosis Type II (ADO II)

  2015cites this paper
• Development of Novel Models for Studying Osteoclasts

  2014cites this paper
• Recent Advances in the Formation and Activation of Osteoclasts

  2014cites this paper
• Regulation of lysosome biogenesis and functions in osteoclasts

  2013cites this paper
• Role of the V-ATPase a3 subunit in osteoclast maturation and function

  2013cites this paper
• Chapter 23 – Sclerosing Bone Disorders

  2013cites this paper
• The Role of GPR55 in Bone Biology

  2013cites this paper
• Autosomal dominant osteopetrosis revisited: lessons from recent studies.

  2013cites this paper
• Friend or foe: high bone mineral density on routine bone density scanning, a review of causes and management.

  2013cites this paper
• Disruption of the V-ATPase functionality as a way to uncouple bone formation and resorption - a novel target for treatment of osteoporosis.

  2012cites this paper
• Report of two Chinese patients suffering from CLCN7-related osteopetrosis and root dysplasia.

  2012cites this paper
• The virulence gene and clinical phenotypes of osteopetrosis in the Chinese population: six novel mutations of the CLCN7 gene in twelve osteopetrosis families

  2012cites this paper
• Cell biology and physiology of CLC chloride channels and transporters.

  2012cites this paper
• Ursache und Verlauf der Bisphosphonat assoziierten Kiefernekrose

  2011cites this paper
• Diseases Affecting Bone Quality: Beyond Osteoporosis

  2011cites this paper
• ClC‐7 is a slowly voltage‐gated 2Cl−/1H+‐exchanger and requires Ostm1 for transport activity

  2011cites this paper
• ClC-5 mutations associated with Dent’s disease: a major role of the dimer interface

  2011cites this paper
• Autosomal dominant osteopetrosis type II.

  2011cites this paper
• Structure of a Eukaryotic CLC Transporter Defines an Intermediate State in the Transport Cycle

  2010cites this paper
• Sclerosing bone disorders: too much of a good thing.

  2010cites this paper
• KAPITEL 42 – Osteosklerosen, Hyperostosen und Osteogenesis imperfecta

  2010cites this paper
• Oculo–orbital manifestations of osteopetrosis in an Indian patient

  2010cites this paper
• Molecular and clinical heterogeneity in CLCN7‐dependent osteopetrosis: report of 20 novel mutations

  2010cites this paper
• Elevated serum lactate dehydrogenase isoenzymes and aspartate transaminase distinguish Albers‐Schönberg disease (Chloride Channel 7 Deficiency Osteopetrosis) among the sclerosing bone disorders

  2010influential citation
• The G215R Mutation in the Cl−/H+-Antiporter ClC-7 Found in ADO II Osteopetrosis Does Not Abolish Function but Causes a Severe Trafficking Defect

  2010cites this paper
• The CLC Family of Chloride Channels and Transporters

  2009cites this paper
• The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data.

  2009cites this paper
• Characterization of the osteopetrotic Clcn7-/- mouse mutant rescued by osteoclast-specific expression of ClC-7

  2009cites this paper
• Identification of the CLCN7 gene mutations in two Chinese families with autosomal dominant osteopetrosis (type II)

  2009cites this paper
• CLC-7: a potential therapeutic target for the treatment of osteoporosis and neurodegeneration.

  2009cites this paper
• Prospects for gene therapy of osteopetrosis.

  2009cites this paper
• Advances in osteoclast biology resulting from the study of osteopetrotic mutations

  2008cites this paper
• The osteoclast: friend or foe?

  2008cites this paper
• Towards a better understanding and new therapeutics of osteopetrosis

  2008cites this paper
• Chapter 72 – Osteopetrosis

  2008cites this paper
• Channelopathies of transepithelial transport and vesicular function.

  2008cites this paper
• CLC Chloride Channels and Transporters: From Genes to Protein Structure, Pathology and Physiology

  2008cites this paper
• Genetics, pathogenesis and complications of osteopetrosis.

  2008cites this paper
• Characterization of the Bone Phenotype in ClC-7-Deficient Mice

  2008cites this paper
• CLCN7 polymorphisms and bone mineral density in healthy premenopausal white women and in white men.

  2008cites this paper
• Autosomal dominant osteopetrosis: clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation.

  2007cites this paper
• Studies on the phenotype and function of osteoclasts using osteopetrotic and rachitic animal models

  2007cites this paper
• Mutations in OSTM1 (Grey Lethal) Define a Particularly Severe Form of Autosomal Recessive Osteopetrosis With Neural Involvement

  2006cites this paper
• Polymorphisms in the CLCN7 gene modulate bone density in postmenopausal women and in patients with autosomal dominant osteopetrosis type II.

  2006cites this paper
• Disease Status in Autosomal Dominant Osteopetrosis Type 2 Is Determined by Osteoclastic Properties

  2006cites this paper
• Single gene mutations and variations affecting bone turnover and strength: a selective 2006 update

  2006cites this paper
• STUDY OF THE ACTIN-RELATED PROTEIN 2/3 COMPLEX AND OSTEOCLAST BONE RESORPTION

  2006cites this paper
• Total hip arthroplasty in osteopetrosis using computer-assisted fluoroscopic navigation.

  2005cites this paper
• Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment

  2005cites this paper
• The genetics of dominant osteopetrosis

  2005cites this paper
• Physiological functions of CLC Cl- channels gleaned from human genetic disease and mouse models.

  2005cites this paper